Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MME | P08473 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6648517 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL10062281 | 0.92 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL10709374 | 0.87 | — | — | |
| SCHEMBL10709369 | 0.87 | — | — | |
| SCHEMBL10347908 | 0.83 | HCAR2 (0.52) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL19889470 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL10347907 | 0.83 | HCAR2 (0.52) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL20867335 | 0.82 | CA1 (0.37) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL27563920 | 0.81 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14CA12KMT2AMEN1 | |
| SCHEMBL10062286 | 0.81 | TSHR (0.39) | SMN1; SMN2CA14CA12KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10066188-B2 | Aroma chemicals | BASF SE (DE) | 2018-09-04 | — | — | US | disclosed |
| EP-3145905-B1 | PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS | BASF SE (DE) | 2018-07-11 | — | — | EP | disclosed |
| EP-3110931-B1 | NOVEL AROMA CHEMICALS | BASF SE (DE) | 2018-04-18 | — | — | EP | disclosed |
| US-9796654-B2 | Process for the dimerization of activated olefins | BASF SE (DE) | 2017-10-24 | — | — | US | disclosed |
| US-20170107168-A1 | PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS | BASF SE (DE) | 2017-04-20 | — | — | US | disclosed |
| EP-3145905-A1 | PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS | BASF SE (DE) | 2017-03-29 | — | — | EP | disclosed |
| EP-3110931-A1 | NOVEL AROMA CHEMICALS | BASF SE (DE) | 2017-01-04 | — | — | EP | disclosed |
| US-20160312149-A1 | NOVEL AROMA CHEMICALS | BASF SE (DE) | 2016-10-27 | — | — | US | disclosed |
| WO-2015177141-A1 | PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS | BASF SE (DE) | 2015-11-26 | — | — | WO | disclosed |
| WO-2015091924-A1 | NOVEL AROMA CHEMICALS | BASF SE (DE) | 2015-06-25 | — | — | WO | disclosed |
| US-6828464-B2 | Preparation of cyclopentenones | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160312149-A1 | NOVEL AROMA CHEMICALS | SRD5A1, SRD5A2, SCD5 | SMN1; SMN2 3423/4885CA14 1157/4885CA12 1104/4885 |
| US-20170107168-A1 | PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS | AOC2, CYP1A2, OXER1 | SMN1; SMN2 4683/4885CA14 3299/4885CA12 1023/4885 |
| US-10066188-B2 | Aroma chemicals | SRD5A2, SRD5A1, SCD5 | SMN1; SMN2 3357/4885CA14 1314/4885CA12 1083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.